Curex

Private

Miami, FloridaHealthcare & Life Scienceshttps://getcurex.com/

Last Round

Series A

Jul 15, 2024

Total Funding Raised

$1M

Company Overview

Curex is a telehealth company that provides a platform for at-home allergy testing, online consultations, and personalized sublingual immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Precision Medicine, Subscription Commerce, D2C Brands, Patient Engagement

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Non-AI

Keywords

sublingual immunotherapyallergy dropsat-home allergy treatmenttelehealthonline allergy clinicallergy shots alternativedirect-to-consumerDTCallergy testingpersonalized immunotherapySLITsubscription medicineat-home allergy testingasthma careeczema careHSA/FSA eligible

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curex Comps

Public and private peers based on sector, stage, and business model.

Curex comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Curex Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 15, 2024
Seed	Jan 28, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Constantine Solow

Chief Operating Officer Chief Financial Officer

Executive Team

Curex Investors

Notable investors and investment history

Curex investors
Investor	Rounds
Plug and Play Tech Center	Seed
Valedor Partners	Seed
Red & Blue Ventures	Seed, Series A
City Light Capital	Seed
Label Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jul 15, 2024
Completed a Series A funding round.
Aug 8, 2023
Grew 67% QoQ, from 36 to 60 employees.

View all signals

Curex Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Curex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Curex's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida

Employee Range100

Year Founded2019

Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.